Hypersomnia (organic)

"Hypersomnia (organic)" References in the ICD-10-CM Index to Diseases and Injuries

References in the ICD-10-CM Index to Diseases and Injuries applicable to the clinical term "hypersomnia (organic)"

  • Hypersomnia (organic) - G47.10 Hypersomnia, unspecified
    • due to
      • alcohol
        • abuse - F10.182 Alcohol abuse with alcohol-induced sleep disorder
        • dependence - F10.282 Alcohol dependence with alcohol-induced sleep disorder
        • use - F10.982 Alcohol use, unspecified with alcohol-induced sleep disorder
      • amphetamines
        • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
        • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
        • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
      • caffeine
        • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
        • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
        • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
      • cocaine
        • abuse - F14.182 Cocaine abuse with cocaine-induced sleep disorder
        • dependence - F14.282 Cocaine dependence with cocaine-induced sleep disorder
        • use - F14.982 Cocaine use, unspecified with cocaine-induced sleep disorder
      • drug NEC
        • abuse - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
        • dependence - F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
        • use - F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
      • medical condition - G47.14 Hypersomnia due to medical condition
      • mental disorder - F51.13 Hypersomnia due to other mental disorder
      • opioid
        • abuse - F11.182 Opioid abuse with opioid-induced sleep disorder
        • dependence - F11.282 Opioid dependence with opioid-induced sleep disorder
        • use - F11.982 Opioid use, unspecified with opioid-induced sleep disorder
      • psychoactive substance NEC
        • abuse - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
        • dependence - F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
        • use - F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
      • sedative, hypnotic, or anxiolytic
        • abuse - F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
        • dependence - F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
        • use - F13.982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
      • stimulant NEC
        • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
        • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
        • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
    • idiopathic - G47.11 Idiopathic hypersomnia with long sleep time
      • with long sleep time - G47.11 Idiopathic hypersomnia with long sleep time
      • without long sleep time - G47.12 Idiopathic hypersomnia without long sleep time
    • nonorganic origin - F51.11 Primary hypersomnia
      • specified NEC - F51.19 Other hypersomnia not due to a substance or known physiological condition
    • not due to a substance or known physiological condition - F51.11 Primary hypersomnia
      • specified NEC - F51.19 Other hypersomnia not due to a substance or known physiological condition
    • primary - F51.11 Primary hypersomnia
    • recurrent - G47.13 Recurrent hypersomnia
    • specified NEC - G47.19 Other hypersomnia

Applicable Clinical Terms Definitions

Amphetamines: Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.

Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.

Cocaine: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.

Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.